KRT14 Antikörper
Kurzübersicht für KRT14 Antikörper (ABIN5557439)
Target
Alle KRT14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- Recombinant human Cytokeratin 14 protein, around C-terminal 150aa.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC-P 1:200-400
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 1xTBS ( pH 7.4), 1 % BSA, 40 %Glycerol and 0.05 % Sodium Azide.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- KRT14 (Keratin 14 (KRT14))
-
Andere Bezeichnung
- Cytokeratin 14
-
Hintergrund
-
Synonyms: K14, NFJ, CK14, EBS3, EBS4, Keratin, type I cytoskeletal 14, Cytokeratin-14, CK-14, Keratin-14, KRT14
Background: The nonhelical tail domain is involved in promoting KRT5-KRT14 filaments to self-organize into large bundles and enhances the mechanical properties involved in resilience of keratin intermediate filaments in vitro.
-
Gen-ID
- 3861
-
UniProt
- P02533
Target
-